Discharge Opioids are Unnecessary Following Radical Cystectomy



      To show that zero-opioid discharges after both open and robotic cystectomy are feasible and to examine the impact of zero-opioid discharges on patient interaction with the physician's office.


      One hundred seven patients who underwent either open or robotic radical cystectomy from March 1, 2020 to December 30, 2020 were identified. Patient demographics, perioperative data, and 30 day pain related outcomes including phone calls, office visits, requests for pain medication, emergency department visits, and readmissions were abstracted from the chart. We then examined variables associated with a zero-opioid discharge.


      Thirty-two patients were discharged with an opioid prescription (Median Oral Morphine Equivalents Prescribed = 90) and 75 were discharged without an opioid prescription. On regression analysis, age (OR 1.07, 95% CI [1.02-1.12]) and pathology (OR 0.36, 95% CI[0.14-0.9]) remained significantly associated with post-operative opioid prescriptions. There were no differences in the percent of patients presenting to the emergency department, being readmitted, calling the office, calling the office regarding pain, or requesting opioid prescriptions within 30 days of discharge, or the number of post-operative office visits (P >.05 for all).


      Patients can safely be discharged home without opioids following cystectomy, regardless of robotic or open approach. Age and pathology are predictors of the need for an opioid prescription on discharge. These patients did not have increased follow-up visits, phone calls, or requests for pain medication.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Enhanced recovery after surgery protocol for patients undergoing ureteroscopy: prospective evaluation of an opioid-free protocol | J Endourol. Accessed February 17, 2022. Available at:

        • Jacobs BL
        • Rogers D
        • Yabes JG
        • et al.
        Large reduction in opioid prescribing by a multipronged behavioral intervention after major urologic surgery.
        Cancer. 2021; 127: 257-265
        • Talwar R
        • Xia L
        • Serna J
        • et al.
        Preventing excess narcotic prescriptions in new robotic surgery discharges: the PENN prospective cohort quality improvement initiative.
        J Endourol. 2020; 34: 48-53
      2. Drug overdose deaths soared to a record 93,000 last year. Washington Post. Available at: Accessed February 17, 2022.

        • Overton HN
        • Hanna MN
        • Bruhn WE
        • Hutfless S
        • Bicket MC
        • Makary MA.
        Opioid-prescribing guidelines for common surgical procedures: an expert panel consensus.
        J Am Coll Surg. 2018; 227: 411-418
        • Berger I
        • Strother M
        • Talwar R
        • et al.
        National variation in opioid prescription fills and long-term use in opioid naïve patients after urological surgery.
        J Urol. 2019; 202: 1036-1043
        • Theisen KM
        • Myrga JM
        • Hale N
        • et al.
        Excessive opioid prescribing after major urologic procedures.
        Urology. 2018; 123: 101-107
        • Bicket MC
        • Long JJ
        • Pronovost PJ
        • Alexander GC
        • Wu CL.
        Prescription opioid analgesics commonly unused after surgery: a systematic review.
        JAMA Surg. 2017; 152: 1066-1071
        • Ziegelmann M
        • Joseph J
        • Glasgow A
        • et al.
        Comparison of prescribing patterns before and after implementation of evidence-based opioid prescribing guidelines for the postoperative urologic surgery patient.
        Am J Surg. 2020; 220: 499-504
        • Greenberg DR
        • Kee JR
        • Stevenson K
        • et al.
        Implementation of a reduced opioid utilization protocol for radical cystectomy.
        Bladder Cancer. 2020; 6: 33-42
        • Audenet F
        • Attalla K
        • Giordano M
        • et al.
        Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion.
        Urol Oncol. 2019; 37: 300.e17-300.e23
        • Pfail JL
        • Garden EB
        • Gul Z
        • et al.
        Implementation of a nonopioid protocol following robot-assisted radical cystectomy with intracorporeal urinary diversion.
        Urol Oncol. 2021; 39: 436.e9-436.e16
      3. AUA position statement: opioid use - american urological association. Accessed February 17, 2022. Available at:

        • Bachman AG
        • Parker AA
        • Shaw MD
        • et al.
        Minimally invasive versus open approach for cystectomy: trends in the utilization and demographic or clinical predictors using the national cancer database.
        Urology. 2017; 103: 99-105
        • Ellis JL
        • Ghiraldi EM
        • Cohn JA
        • et al.
        Prescribing trends in post-operative pain management after urologic surgery: a quality care investigation for Healthcare providers.
        Urology. 2021; 153: 156-163
        • Clarke H
        • Soneji N
        • Ko DT
        • Yun L
        • Wijeysundera DN.
        Rates and risk factors for prolonged opioid use after major surgery: population based cohort study.
        BMJ. 2014; 348: g1251